|
Glaxo's experimental drug slows breast cancer spread by half - Jun. 3, 2006
I do like what it says here especially since I am on a clinical trial consisting of Herceptin, Taxol and Tykerb and so far I am responding well:
Amusa said that Tykerb might be used in conjunction with Herceptin to treat all forms of HER2 breast cancer, and the drug could be key in transforming breast cancer from a deadly disease to a chronic one.
|